NICE guidance in schizophrenia: How generalisable are drug trials?
Aims and method: To test the National Institute for Clinical Excellence (NICE) assertion that characteristics of participants in the majority of clinical drug trials in schizophrenia do not reflect clinical practice. In particular they were concerned about the relative exclusion of women, older adul...
Autor principal: | Burns, T |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2006
|
Ítems similars
-
Diagnosis and management of endometriosis: summary of NICE guidance
per: Kuznetsov, L, et al.
Publicat: (2017) -
NICE guidance to working with real-world data
per: A. Sh. Motrinchuk, et al.
Publicat: (2023-01-01) -
Commentary: Controversies in NICE guidance on chronic kidney disease.
per: Landray, M, et al.
Publicat: (2008) -
Management of hip fracture in adults: summary of NICE guidance.
per: Ftouh, S, et al.
Publicat: (2011) -
Commentary: Controversies in NICE guidance on chronic kidney disease
per: Landray, M, et al.
Publicat: (2008)